GLP-1C + Semaglutide Blend 5mg + 5mg (Lyophilized Powder) For Research Use Only
GLP-1 C-S is a research blend combining GLP-1C (cagrilintide-based dual agonist) and GLP-1S (Semaglutide) to study the additive or synergistic effects of multiple GLP-1 and amylin pathway activations on metabolic regulation, weight loss, and satiety.
Research suggests this combination may deliver multi-mechanistic appetite suppression, enhanced glycemic control, and potentiated weight reduction outcomes compared to either compound alone.
Product Details:
-
Peptides: GLP-1C (5mg) + GLP-1S (5mg)
-
Purity: >98% each
-
Form: Lyophilized powder blend
-
Quantity: 10mg total (5mg + 5mg) per vial
-
Storage: Store at -4°F (-20°C). After reconstitution, refrigerate at 36°F (2–8°C) and use within 28 days.
-
Grade: For research purposes only. Not for human consumption, therapeutic, or diagnostic use.
Potential Research Applications:
-
Multi-pathway GLP-1 and amylin agonism studies
-
Combination metabolic therapy research models
-
Advanced obesity and weight management investigations
-
Glycemic and satiety synergy studies
For laboratory research use only. This product is not intended to diagnose, treat, cure, or prevent any disease.
